Efficacy and safety of blinatumomab for the treatment of patients relapsing after allogeneic hematopoietic cell transplantation: a systemic review and meta-analysis
Objective We aim to evaluate the efficacy and safety of blinatumomab for the treatment of post-transplant relapse patients with acute lymphoblastic leukemia (ALL).Methods The search was conducted using several databases including the PubMed, Cochrane Library, Embase, Chinese National Knowledge Infra...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis Group
2024-12-01
|
| Col·lecció: | Hematology |
| Matèries: | |
| Accés en línia: | https://www.tandfonline.com/doi/10.1080/16078454.2024.2422151 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|